Merck Sharp & Dohme Co. Ltd.

Hod HaSharon

1 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Classical Hodgkin Lymphoma, Colorectal Cancer, Gastric Cancer, Lymphoma, Melanoma, Microsatellite-instability-high Solid Tumor, Non-small Cell Lung Carcinoma (NSCLC), Ovarian Cancer, Solid Tumor

Studies at this site

• A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) — Recruiting now
• Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) — Stopped early